English
简体中文
Total: £ 56.28
Published Date: 2025-02-20 | Pages: 92 | Tables: 91 | Medical Care
The global market for Co-immunoprecipitation (Co-IP) Service was valued at US$ 477 million in the year 2024 and is projected to reach a revised size of US$ 676 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Co-immunoprecipitation (Co-IP) service is a method for studying protein interactions based on the interaction between antibodies and antigens. The principle is to use endogenous target proteins in cells as bait, co incubate target protein antibodies with total cell proteins, and promote the formation of immune complexes. Subsequently, protein A/G that can bind to the target protein antibody is added to form a "binding protein target protein target protein antibody" complex. After purification, the immune complex is separated by gel electrophoresis, combined with Western blot or mass spectrometry technology, so as to purify the target protein and qualitatively detect antigen or antibody.
North American market for Co-immunoprecipitation (Co-IP) Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Co-immunoprecipitation (Co-IP) Service is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Co-immunoprecipitation (Co-IP) Service in Drug Development is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Co-immunoprecipitation (Co-IP) Service include Creative Proteomics, Lifeasible, ThermoFisher Scientific, Profacgen, Creative BioMart, Biologics International Corp, Creative Diagnostics, CD BioSciences, Beijing Abace Biology, Nanjing Detai Bioengineering, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Co-immunoprecipitation (Co-IP) Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Co-immunoprecipitation (Co-IP) Service.
The Co-immunoprecipitation (Co-IP) Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Co-immunoprecipitation (Co-IP) Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Co-immunoprecipitation (Co-IP) Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Creative Proteomics
Lifeasible
ThermoFisher Scientific
Profacgen
Creative BioMart
Biologics International Corp
Creative Diagnostics
CD BioSciences
Beijing Abace Biology
Nanjing Detai Bioengineering
Guangzhou Fitgene Biotechnology
Nanjing Zoonbio Biotechnology
Shanghai Beyotime Biotechnology
Beijing Bio-Tech Pack Scientific
Wuhan Genecreate
Wuhan Biorun BioSciences
Segment by Type
Tag Protein Immunoprecipitation
Non Tagged Protein Immunoprecipitation
Chromatin Immunoprecipitation
Segment by Application
Drug Development
Biomedical Research
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Co-immunoprecipitation (Co-IP) Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Co-immunoprecipitation (Co-IP) Service Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tag Protein Immunoprecipitation
1.2.3 Non Tagged Protein Immunoprecipitation
1.2.4 Chromatin Immunoprecipitation
1.3 Market by Application
1.3.1 Global Co-immunoprecipitation (Co-IP) Service Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Development
1.3.3 Biomedical Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Co-immunoprecipitation (Co-IP) Service Market Perspective (2020-2031)
2.2 Global Co-immunoprecipitation (Co-IP) Service Growth Trends by Region
2.2.1 Global Co-immunoprecipitation (Co-IP) Service Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Co-immunoprecipitation (Co-IP) Service Historic Market Size by Region (2020-2025)
2.2.3 Co-immunoprecipitation (Co-IP) Service Forecasted Market Size by Region (2026-2031)
2.3 Co-immunoprecipitation (Co-IP) Service Market Dynamics
2.3.1 Co-immunoprecipitation (Co-IP) Service Industry Trends
2.3.2 Co-immunoprecipitation (Co-IP) Service Market Drivers
2.3.3 Co-immunoprecipitation (Co-IP) Service Market Challenges
2.3.4 Co-immunoprecipitation (Co-IP) Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Co-immunoprecipitation (Co-IP) Service Players by Revenue
3.1.1 Global Top Co-immunoprecipitation (Co-IP) Service Players by Revenue (2020-2025)
3.1.2 Global Co-immunoprecipitation (Co-IP) Service Revenue Market Share by Players (2020-2025)
3.2 Global Top Co-immunoprecipitation (Co-IP) Service Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Co-immunoprecipitation (Co-IP) Service Revenue
3.4 Global Co-immunoprecipitation (Co-IP) Service Market Concentration Ratio
3.4.1 Global Co-immunoprecipitation (Co-IP) Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Co-immunoprecipitation (Co-IP) Service Revenue in 2024
3.5 Global Key Players of Co-immunoprecipitation (Co-IP) Service Head office and Area Served
3.6 Global Key Players of Co-immunoprecipitation (Co-IP) Service, Product and Application
3.7 Global Key Players of Co-immunoprecipitation (Co-IP) Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Co-immunoprecipitation (Co-IP) Service Breakdown Data by Type
4.1 Global Co-immunoprecipitation (Co-IP) Service Historic Market Size by Type (2020-2025)
4.2 Global Co-immunoprecipitation (Co-IP) Service Forecasted Market Size by Type (2026-2031)
5 Co-immunoprecipitation (Co-IP) Service Breakdown Data by Application
5.1 Global Co-immunoprecipitation (Co-IP) Service Historic Market Size by Application (2020-2025)
5.2 Global Co-immunoprecipitation (Co-IP) Service Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Co-immunoprecipitation (Co-IP) Service Market Size (2020-2031)
6.2 North America Co-immunoprecipitation (Co-IP) Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Co-immunoprecipitation (Co-IP) Service Market Size by Country (2020-2025)
6.4 North America Co-immunoprecipitation (Co-IP) Service Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Co-immunoprecipitation (Co-IP) Service Market Size (2020-2031)
7.2 Europe Co-immunoprecipitation (Co-IP) Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Co-immunoprecipitation (Co-IP) Service Market Size by Country (2020-2025)
7.4 Europe Co-immunoprecipitation (Co-IP) Service Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Co-immunoprecipitation (Co-IP) Service Market Size (2020-2031)
8.2 Asia-Pacific Co-immunoprecipitation (Co-IP) Service Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Co-immunoprecipitation (Co-IP) Service Market Size by Region (2020-2025)
8.4 Asia-Pacific Co-immunoprecipitation (Co-IP) Service Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Co-immunoprecipitation (Co-IP) Service Market Size (2020-2031)
9.2 Latin America Co-immunoprecipitation (Co-IP) Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Co-immunoprecipitation (Co-IP) Service Market Size by Country (2020-2025)
9.4 Latin America Co-immunoprecipitation (Co-IP) Service Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Co-immunoprecipitation (Co-IP) Service Market Size (2020-2031)
10.2 Middle East & Africa Co-immunoprecipitation (Co-IP) Service Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Co-immunoprecipitation (Co-IP) Service Market Size by Country (2020-2025)
10.4 Middle East & Africa Co-immunoprecipitation (Co-IP) Service Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Creative Proteomics
11.1.1 Creative Proteomics Company Details
11.1.2 Creative Proteomics Business Overview
11.1.3 Creative Proteomics Co-immunoprecipitation (Co-IP) Service Introduction
11.1.4 Creative Proteomics Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
11.1.5 Creative Proteomics Recent Development
11.2 Lifeasible
11.2.1 Lifeasible Company Details
11.2.2 Lifeasible Business Overview
11.2.3 Lifeasible Co-immunoprecipitation (Co-IP) Service Introduction
11.2.4 Lifeasible Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
11.2.5 Lifeasible Recent Development
11.3 ThermoFisher Scientific
11.3.1 ThermoFisher Scientific Company Details
11.3.2 ThermoFisher Scientific Business Overview
11.3.3 ThermoFisher Scientific Co-immunoprecipitation (Co-IP) Service Introduction
11.3.4 ThermoFisher Scientific Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
11.3.5 ThermoFisher Scientific Recent Development
11.4 Profacgen
11.4.1 Profacgen Company Details
11.4.2 Profacgen Business Overview
11.4.3 Profacgen Co-immunoprecipitation (Co-IP) Service Introduction
11.4.4 Profacgen Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
11.4.5 Profacgen Recent Development
11.5 Creative BioMart
11.5.1 Creative BioMart Company Details
11.5.2 Creative BioMart Business Overview
11.5.3 Creative BioMart Co-immunoprecipitation (Co-IP) Service Introduction
11.5.4 Creative BioMart Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
11.5.5 Creative BioMart Recent Development
11.6 Biologics International Corp
11.6.1 Biologics International Corp Company Details
11.6.2 Biologics International Corp Business Overview
11.6.3 Biologics International Corp Co-immunoprecipitation (Co-IP) Service Introduction
11.6.4 Biologics International Corp Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
11.6.5 Biologics International Corp Recent Development
11.7 Creative Diagnostics
11.7.1 Creative Diagnostics Company Details
11.7.2 Creative Diagnostics Business Overview
11.7.3 Creative Diagnostics Co-immunoprecipitation (Co-IP) Service Introduction
11.7.4 Creative Diagnostics Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
11.7.5 Creative Diagnostics Recent Development
11.8 CD BioSciences
11.8.1 CD BioSciences Company Details
11.8.2 CD BioSciences Business Overview
11.8.3 CD BioSciences Co-immunoprecipitation (Co-IP) Service Introduction
11.8.4 CD BioSciences Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
11.8.5 CD BioSciences Recent Development
11.9 Beijing Abace Biology
11.9.1 Beijing Abace Biology Company Details
11.9.2 Beijing Abace Biology Business Overview
11.9.3 Beijing Abace Biology Co-immunoprecipitation (Co-IP) Service Introduction
11.9.4 Beijing Abace Biology Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
11.9.5 Beijing Abace Biology Recent Development
11.10 Nanjing Detai Bioengineering
11.10.1 Nanjing Detai Bioengineering Company Details
11.10.2 Nanjing Detai Bioengineering Business Overview
11.10.3 Nanjing Detai Bioengineering Co-immunoprecipitation (Co-IP) Service Introduction
11.10.4 Nanjing Detai Bioengineering Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
11.10.5 Nanjing Detai Bioengineering Recent Development
11.11 Guangzhou Fitgene Biotechnology
11.11.1 Guangzhou Fitgene Biotechnology Company Details
11.11.2 Guangzhou Fitgene Biotechnology Business Overview
11.11.3 Guangzhou Fitgene Biotechnology Co-immunoprecipitation (Co-IP) Service Introduction
11.11.4 Guangzhou Fitgene Biotechnology Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
11.11.5 Guangzhou Fitgene Biotechnology Recent Development
11.12 Nanjing Zoonbio Biotechnology
11.12.1 Nanjing Zoonbio Biotechnology Company Details
11.12.2 Nanjing Zoonbio Biotechnology Business Overview
11.12.3 Nanjing Zoonbio Biotechnology Co-immunoprecipitation (Co-IP) Service Introduction
11.12.4 Nanjing Zoonbio Biotechnology Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
11.12.5 Nanjing Zoonbio Biotechnology Recent Development
11.13 Shanghai Beyotime Biotechnology
11.13.1 Shanghai Beyotime Biotechnology Company Details
11.13.2 Shanghai Beyotime Biotechnology Business Overview
11.13.3 Shanghai Beyotime Biotechnology Co-immunoprecipitation (Co-IP) Service Introduction
11.13.4 Shanghai Beyotime Biotechnology Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
11.13.5 Shanghai Beyotime Biotechnology Recent Development
11.14 Beijing Bio-Tech Pack Scientific
11.14.1 Beijing Bio-Tech Pack Scientific Company Details
11.14.2 Beijing Bio-Tech Pack Scientific Business Overview
11.14.3 Beijing Bio-Tech Pack Scientific Co-immunoprecipitation (Co-IP) Service Introduction
11.14.4 Beijing Bio-Tech Pack Scientific Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
11.14.5 Beijing Bio-Tech Pack Scientific Recent Development
11.15 Wuhan Genecreate
11.15.1 Wuhan Genecreate Company Details
11.15.2 Wuhan Genecreate Business Overview
11.15.3 Wuhan Genecreate Co-immunoprecipitation (Co-IP) Service Introduction
11.15.4 Wuhan Genecreate Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
11.15.5 Wuhan Genecreate Recent Development
11.16 Wuhan Biorun BioSciences
11.16.1 Wuhan Biorun BioSciences Company Details
11.16.2 Wuhan Biorun BioSciences Business Overview
11.16.3 Wuhan Biorun BioSciences Co-immunoprecipitation (Co-IP) Service Introduction
11.16.4 Wuhan Biorun BioSciences Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
11.16.5 Wuhan Biorun BioSciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Co-immunoprecipitation (Co-IP) Service Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Tag Protein Immunoprecipitation
Table 3. Key Players of Non Tagged Protein Immunoprecipitation
Table 4. Key Players of Chromatin Immunoprecipitation
Table 5. Global Co-immunoprecipitation (Co-IP) Service Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Co-immunoprecipitation (Co-IP) Service Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Co-immunoprecipitation (Co-IP) Service Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Co-immunoprecipitation (Co-IP) Service Market Share by Region (2020-2025)
Table 9. Global Co-immunoprecipitation (Co-IP) Service Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Co-immunoprecipitation (Co-IP) Service Market Share by Region (2026-2031)
Table 11. Co-immunoprecipitation (Co-IP) Service Market Trends
Table 12. Co-immunoprecipitation (Co-IP) Service Market Drivers
Table 13. Co-immunoprecipitation (Co-IP) Service Market Challenges
Table 14. Co-immunoprecipitation (Co-IP) Service Market Restraints
Table 15. Global Co-immunoprecipitation (Co-IP) Service Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Co-immunoprecipitation (Co-IP) Service Market Share by Players (2020-2025)
Table 17. Global Top Co-immunoprecipitation (Co-IP) Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Co-immunoprecipitation (Co-IP) Service as of 2024)
Table 18. Ranking of Global Top Co-immunoprecipitation (Co-IP) Service Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Co-immunoprecipitation (Co-IP) Service Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Co-immunoprecipitation (Co-IP) Service, Headquarters and Area Served
Table 21. Global Key Players of Co-immunoprecipitation (Co-IP) Service, Product and Application
Table 22. Global Key Players of Co-immunoprecipitation (Co-IP) Service, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Co-immunoprecipitation (Co-IP) Service Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Co-immunoprecipitation (Co-IP) Service Revenue Market Share by Type (2020-2025)
Table 26. Global Co-immunoprecipitation (Co-IP) Service Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Co-immunoprecipitation (Co-IP) Service Revenue Market Share by Type (2026-2031)
Table 28. Global Co-immunoprecipitation (Co-IP) Service Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Co-immunoprecipitation (Co-IP) Service Revenue Market Share by Application (2020-2025)
Table 30. Global Co-immunoprecipitation (Co-IP) Service Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Co-immunoprecipitation (Co-IP) Service Revenue Market Share by Application (2026-2031)
Table 32. North America Co-immunoprecipitation (Co-IP) Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Co-immunoprecipitation (Co-IP) Service Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Co-immunoprecipitation (Co-IP) Service Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Co-immunoprecipitation (Co-IP) Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Co-immunoprecipitation (Co-IP) Service Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Co-immunoprecipitation (Co-IP) Service Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Co-immunoprecipitation (Co-IP) Service Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Co-immunoprecipitation (Co-IP) Service Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Co-immunoprecipitation (Co-IP) Service Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Co-immunoprecipitation (Co-IP) Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Co-immunoprecipitation (Co-IP) Service Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Co-immunoprecipitation (Co-IP) Service Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Co-immunoprecipitation (Co-IP) Service Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Co-immunoprecipitation (Co-IP) Service Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Co-immunoprecipitation (Co-IP) Service Market Size by Country (2026-2031) & (US$ Million)
Table 47. Creative Proteomics Company Details
Table 48. Creative Proteomics Business Overview
Table 49. Creative Proteomics Co-immunoprecipitation (Co-IP) Service Product
Table 50. Creative Proteomics Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)
Table 51. Creative Proteomics Recent Development
Table 52. Lifeasible Company Details
Table 53. Lifeasible Business Overview
Table 54. Lifeasible Co-immunoprecipitation (Co-IP) Service Product
Table 55. Lifeasible Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)
Table 56. Lifeasible Recent Development
Table 57. ThermoFisher Scientific Company Details
Table 58. ThermoFisher Scientific Business Overview
Table 59. ThermoFisher Scientific Co-immunoprecipitation (Co-IP) Service Product
Table 60. ThermoFisher Scientific Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)
Table 61. ThermoFisher Scientific Recent Development
Table 62. Profacgen Company Details
Table 63. Profacgen Business Overview
Table 64. Profacgen Co-immunoprecipitation (Co-IP) Service Product
Table 65. Profacgen Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)
Table 66. Profacgen Recent Development
Table 67. Creative BioMart Company Details
Table 68. Creative BioMart Business Overview
Table 69. Creative BioMart Co-immunoprecipitation (Co-IP) Service Product
Table 70. Creative BioMart Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)
Table 71. Creative BioMart Recent Development
Table 72. Biologics International Corp Company Details
Table 73. Biologics International Corp Business Overview
Table 74. Biologics International Corp Co-immunoprecipitation (Co-IP) Service Product
Table 75. Biologics International Corp Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)
Table 76. Biologics International Corp Recent Development
Table 77. Creative Diagnostics Company Details
Table 78. Creative Diagnostics Business Overview
Table 79. Creative Diagnostics Co-immunoprecipitation (Co-IP) Service Product
Table 80. Creative Diagnostics Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)
Table 81. Creative Diagnostics Recent Development
Table 82. CD BioSciences Company Details
Table 83. CD BioSciences Business Overview
Table 84. CD BioSciences Co-immunoprecipitation (Co-IP) Service Product
Table 85. CD BioSciences Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)
Table 86. CD BioSciences Recent Development
Table 87. Beijing Abace Biology Company Details
Table 88. Beijing Abace Biology Business Overview
Table 89. Beijing Abace Biology Co-immunoprecipitation (Co-IP) Service Product
Table 90. Beijing Abace Biology Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)
Table 91. Beijing Abace Biology Recent Development
Table 92. Nanjing Detai Bioengineering Company Details
Table 93. Nanjing Detai Bioengineering Business Overview
Table 94. Nanjing Detai Bioengineering Co-immunoprecipitation (Co-IP) Service Product
Table 95. Nanjing Detai Bioengineering Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)
Table 96. Nanjing Detai Bioengineering Recent Development
Table 97. Guangzhou Fitgene Biotechnology Company Details
Table 98. Guangzhou Fitgene Biotechnology Business Overview
Table 99. Guangzhou Fitgene Biotechnology Co-immunoprecipitation (Co-IP) Service Product
Table 100. Guangzhou Fitgene Biotechnology Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)
Table 101. Guangzhou Fitgene Biotechnology Recent Development
Table 102. Nanjing Zoonbio Biotechnology Company Details
Table 103. Nanjing Zoonbio Biotechnology Business Overview
Table 104. Nanjing Zoonbio Biotechnology Co-immunoprecipitation (Co-IP) Service Product
Table 105. Nanjing Zoonbio Biotechnology Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)
Table 106. Nanjing Zoonbio Biotechnology Recent Development
Table 107. Shanghai Beyotime Biotechnology Company Details
Table 108. Shanghai Beyotime Biotechnology Business Overview
Table 109. Shanghai Beyotime Biotechnology Co-immunoprecipitation (Co-IP) Service Product
Table 110. Shanghai Beyotime Biotechnology Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)
Table 111. Shanghai Beyotime Biotechnology Recent Development
Table 112. Beijing Bio-Tech Pack Scientific Company Details
Table 113. Beijing Bio-Tech Pack Scientific Business Overview
Table 114. Beijing Bio-Tech Pack Scientific Co-immunoprecipitation (Co-IP) Service Product
Table 115. Beijing Bio-Tech Pack Scientific Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)
Table 116. Beijing Bio-Tech Pack Scientific Recent Development
Table 117. Wuhan Genecreate Company Details
Table 118. Wuhan Genecreate Business Overview
Table 119. Wuhan Genecreate Co-immunoprecipitation (Co-IP) Service Product
Table 120. Wuhan Genecreate Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)
Table 121. Wuhan Genecreate Recent Development
Table 122. Wuhan Biorun BioSciences Company Details
Table 123. Wuhan Biorun BioSciences Business Overview
Table 124. Wuhan Biorun BioSciences Co-immunoprecipitation (Co-IP) Service Product
Table 125. Wuhan Biorun BioSciences Revenue in Co-immunoprecipitation (Co-IP) Service Business (2020-2025) & (US$ Million)
Table 126. Wuhan Biorun BioSciences Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
Table 130. Authors List of This Report
List of Figures
Figure 1. Co-immunoprecipitation (Co-IP) Service Picture
Figure 2. Global Co-immunoprecipitation (Co-IP) Service Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Co-immunoprecipitation (Co-IP) Service Market Share by Type: 2024 VS 2031
Figure 4. Tag Protein Immunoprecipitation Features
Figure 5. Non Tagged Protein Immunoprecipitation Features
Figure 6. Chromatin Immunoprecipitation Features
Figure 7. Global Co-immunoprecipitation (Co-IP) Service Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Co-immunoprecipitation (Co-IP) Service Market Share by Application: 2024 VS 2031
Figure 9. Drug Development Case Studies
Figure 10. Biomedical Research Case Studies
Figure 11. Co-immunoprecipitation (Co-IP) Service Report Years Considered
Figure 12. Global Co-immunoprecipitation (Co-IP) Service Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Co-immunoprecipitation (Co-IP) Service Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Co-immunoprecipitation (Co-IP) Service Market Share by Region: 2024 VS 2031
Figure 15. Global Co-immunoprecipitation (Co-IP) Service Market Share by Players in 2024
Figure 16. Global Co-immunoprecipitation (Co-IP) Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Co-immunoprecipitation (Co-IP) Service Revenue in 2024
Figure 18. North America Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Co-immunoprecipitation (Co-IP) Service Market Share by Country (2020-2031)
Figure 20. United States Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Co-immunoprecipitation (Co-IP) Service Market Share by Country (2020-2031)
Figure 24. Germany Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Co-immunoprecipitation (Co-IP) Service Market Share by Region (2020-2031)
Figure 32. China Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Co-immunoprecipitation (Co-IP) Service Market Share by Country (2020-2031)
Figure 40. Mexico Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Co-immunoprecipitation (Co-IP) Service Market Share by Country (2020-2031)
Figure 44. Turkey Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Co-immunoprecipitation (Co-IP) Service Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Creative Proteomics Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
Figure 48. Lifeasible Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
Figure 49. ThermoFisher Scientific Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
Figure 50. Profacgen Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
Figure 51. Creative BioMart Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
Figure 52. Biologics International Corp Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
Figure 53. Creative Diagnostics Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
Figure 54. CD BioSciences Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
Figure 55. Beijing Abace Biology Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
Figure 56. Nanjing Detai Bioengineering Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
Figure 57. Guangzhou Fitgene Biotechnology Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
Figure 58. Nanjing Zoonbio Biotechnology Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
Figure 59. Shanghai Beyotime Biotechnology Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
Figure 60. Beijing Bio-Tech Pack Scientific Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
Figure 61. Wuhan Genecreate Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
Figure 62. Wuhan Biorun BioSciences Revenue Growth Rate in Co-immunoprecipitation (Co-IP) Service Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
